인쇄하기
취소
|
In the 1st quarter of this year, KOSPI listed pharmaceutical companies have spent twice more into R&D than what KOSDAQ listed pharmaceutical companies spent.
Yakup Shinmoon(www.yakup.com) analyzed R&D expenses that 38 KOSPI and 31 KOSDAQ listed pharmaceutical companies spent in this 1st quarter, and KOSPI pharmaceutical companies had a 23.8% increase in R&D year-on-year while KOSDAQ pharmaceut...